Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia

被引：0
|
作者：
Minu Singh
Divya Bhaskar
Prateek Bhatia
Rozy Thakur
Pankaj Sharma
Deepak Bansal
Richa Jain
Amita Trehan
机构：
[1] Postgraduate Institute of Medical Education and Research,Haematology
来源：
Cancer Chemotherapy and Pharmacology | 2023年 / 92卷
关键词：
ALL; Thiopurine; Maintenance phase; Chemotherapy; IBD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：51 / 56
页数：5
相关论文
共 50 条
  • [31] CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - PHARMACOGENETIC VARIATION IN RESPONSE TO 6-MERCAPTOPURINE
    LENNARD, L
    LILLEYMAN, JS
    VANLOON, J
    WEINSHILBOUM, RM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : P324 - P324
  • [32] Severe Recurrent Nocturnal Hypoglycemia During Chemotherapy With 6-mercaptopurine in 2 Children With Acute Lymphoblastic Leukemia
    Albiroty, Khalil
    Al Sabahi, Amal
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (03) : 162 - 163
  • [33] DISPOSITION OF ORAL METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND ITS RELATION TO 6-MERCAPTOPURINE PHARMACOKINETICS
    KOREN, G
    SOLH, H
    KLEIN, J
    SOLDIN, SJ
    GREENBERG, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (06): : 450 - 454
  • [34] FAT-BODY MASS AND PHARMACOKINETICS OF ORAL 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    ZUCCARO, P
    GUANDALINI, S
    PACIFICI, R
    PICHINI, S
    DIMARTINO, L
    GUIDUCCI, M
    GIULIANO, M
    DITULLIO, MT
    MANTOVANI, MP
    THERAPEUTIC DRUG MONITORING, 1991, 13 (01) : 37 - 41
  • [35] IS 6-Mercaptopurine Suspension Therapeutically Equivalent to Tablet in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy?
    De Beaumais, T. Adam
    Benchikh, A.
    Medard, Y.
    Simonin, M.
    Magreault, S.
    Tabone, M. D.
    Jacqz-Aigrain, E.
    Petit, A.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S571 - S572
  • [36] USE OF ALLOPURINOL TO REDIRECT 6-MERCAPTOPURINE METABOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Stuckert, Austin
    Schafer, Eric
    Bernhardt, M. Brooke
    Baxter, Patricia
    Brackett, Julienne
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [37] PHARMACOKINETIC DETERMINANTS OF 6-MERCAPTOPURINE, MYELOTOXICITY AND THERAPEUTIC FAILURE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    WHALEN, CE
    SOLDIN, SJ
    SULH, H
    KOREN, G
    GREENBERG, M
    CLINICAL CHEMISTRY, 1986, 32 (06) : 1092 - 1092
  • [38] ARE CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA RESISTANT TO 6-MERCAPTOPURINE BECAUSE OF 5'-NUCLEOTIDASE
    PIETERS, R
    HUISMANS, DR
    VEERMAN, AJP
    LANCET, 1987, 2 (8573): : 1471 - 1471
  • [39] INFLUENCE OF FOOD-INTAKE ON BIOAVAILABILITY OF ORAL 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    RICCARDI, R
    BALIS, FM
    FERRARA, P
    LASORELLA, A
    POPLACK, DG
    MASTRANGELO, R
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1986, 3 (04) : 319 - 324
  • [40] PHARMACOKINETICS (PK) OF TWO 6-MERCAPTOPURINE (6-MP) LIQUID FORMULATIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL).
    Tolbert, J. A.
    Kearns, G. L.
    Abdel-Rahman, S. M.
    Weir, S. J.
    Leeder, J. S.
    Neville, K. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S94 - S94
12345